Home » Topics » BioWorld Science

BioWorld Science
RSS

Antifungal activity of KP-103 under evaluation

Nov. 24, 1997

Palatin receives FDA clearance to start LeuTech clinical trials

Nov. 24, 1997

Doxil/Caelyx evaluated in phase II for advanced breast cancer

Nov. 24, 1997

NK3 antagonist demonstrates intestinal antiinflammatory activity

Nov. 24, 1997

FDA advisory committee recommends approval of Rocephin for AOM

Nov. 24, 1997

Role of substance P in PTH secretion described

Nov. 24, 1997

New NK1 antagonist from Novartis

Nov. 24, 1997

Six-month trial of lamivudine for chronic hepatitis B

Nov. 24, 1997

Phase I trial of multiple-dose IDEC-C2B8 in NHL

Nov. 24, 1997

Role of complement in mast cell-dependent natural immunity

Nov. 24, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...